Changing Glucose Tolerance during Pregnancy—Implications for Diagnosis of Gestational Diabetes Mellitus (GDM)

Author:

KNOWLER WILLIAM C.1,DREWS KIMBERLY1,REDMAN LEANNE1,JOSHIPURA KAUMUDI J.1,ARTEAGA S. SONIA1,PI-SUNYER XAVIER1,HORN LINDA VAN1,WING RENA R.1,KLEIN SAMUEL1,

Affiliation:

1. Phoenix, AZ, Rockville, MD, Baton Rouge, LA, San Juan, PR, Bethesda, MD, New York, NY, Chicago, IL, Providence, RI, St. Louis, MO

Abstract

Background: ADA recommends testing for GDM at 24-28 weeks gestation. This recommendation is based on the assumption that glucose tolerance worsens during pregnancy and, therefore, testing earlier in pregnancy will miss many cases that develop only later. We tested this assumption in the LIFE-Moms consortium. Methods: LIFE-Moms was a consortium of randomized clinical trials of lifestyle interventions aimed at limiting gestational weight gain compared with standard care in 1,150 pregnant women with BMI ≥25 kg/m2 recruited from different racial/ethnic groups in the U.S. Women with known or probable diabetes preceding this pregnancy were excluded. As previously reported, the lifestyle interventions modestly reduced excessive gestational weight gain (the primary outcome) but had no significant effect on the prevalence of GDM at 24-31 weeks. We report here results of 75 g 2-hour OGTTs performed sequentially during pregnancy in a subset of 296 women tested at <16 weeks (mean 12.6 weeks) gestation and again at 24-31 weeks. Tests were interpreted by the International Association of Diabetes in Pregnancy Study Groups (IADPSG) criteria. Results: Plasma or serum glucose declined from the early to later tests by a mean of 2.5 mg/dl (fasting), 10.9 mg/dl (1-hr), and 9.3 mg/dl (2-hr), each p<0.0001. The prevalence of GDM by IADPSG criteria declined from 20% at <16 weeks gestation to 15% at 24-31 weeks (p=0.04). Only 9% of women without GDM at <16 weeks gestation developed it by 24-31 weeks, whereas 65% of those meeting GDM criteria at <16 weeks gestation did not meet GDM criteria at follow-up. None of the changes in glucose or GDM prevalence differed significantly by treatment group. Conclusions: In pregnant women with BMI ≥25 kg/m2 who are otherwise healthy, glucose tolerance improves on average rather than deteriorates during gestation. Testing for GDM early in pregnancy is needed to understand pregnancy effects on glycemia and the clinical implications of earlier detection of GDM. Disclosure W.C. Knowler: None. K. Drews: None. L. Redman: None. K.J. Joshipura: None. S. Arteaga: None. X. Pi-Sunyer: None. L. Van Horn: None. R.R. Wing: None. S. Klein: Stock/Shareholder; Self; Aspire Bariatrics. Consultant; Self; Pfizer Inc.. Research Support; Self; Merck & Co., Inc., Johnson & Johnson Services, Inc., REMD Biotherapeutics.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3